News

B2S Life Sciences welcomes new Project Manager

Posted by on Jul 7, 2017 in News | 0 comments

B2S Life Sciences proudly announces the arrival of new project manager, Mr. Michael Chiappetta.  Mr. Chiappetta has dedicated the last 35 years to the commercialization of biotechnology products.  His experience has ranged from working for a breakthrough start-up company called Hybritech, noted for its contributions to the forefront of monoclonal antibody products, to a distinguished tenure at Eli Lilly and Company.  While at Lilly, Mike was instrumental in the development and commercialization of multiple pharmaceutical products.  Prior to...

read more

A next generation antibody for measuring Glargine (Lantus®)with high specificity

Posted by on Feb 28, 2017 in News | 0 comments

B2S Life Sciences has developed another next generation antibody to support diabetes research.  This Protein‐A purified polyclonal guinea pig antiserum was specifically prepared to provide investigators with an insulin antiserum that demonstrates preferential binding to insulin glargine ﴾Lantus®﴿, a widely‐used basal insulin therapeutic. The antiserum is suitable for use in ELISAs/RIAs, as an immunoaffinity capture reagent in LC‐MS/MS assays and for preparation of serum QCs for use in assays to detect and characterize ADA to glargine. The...

read more

New affinity purified broad specificity anti-human insulin antibody available

Posted by on Feb 17, 2017 in News | 0 comments

B2S Life Sciences has been developing a new series of antibodies that are designed to improve the detection of insulin and insulin analog therapeutics.  The first available in this series is a broad specificity anti-human insulin antibody.  This affinity purified polyclonal antiserum was specifically prepared to provide broad cross‐reactivity with human insulin and common insulin analogs to allow use in ELISAs/RIAs and as an immunoaffinity capture reagent in LC‐MS/MS assays.  The immunogen consisted of pharma‐grade insulin. Following...

read more

B2S Labs launches e-commerce store

Posted by on Jul 21, 2015 in News | 0 comments

B2S Labs launches e-commerce store

B2S Labs is proud to announce that its e-commerce shop is now live. Visit b2slabs.com/shop to access the shop directly. Click on the “Shop” option under the “Catalog” menu (found at the top of any B2SLabs.com Web page) to navigate to the shop. It is mobile-friendly. The shop currently features a polyclonal antibody, and additional products will become available for purchase online in the near future. Products featured in the online shop will include reagents, peptides, proteins, kits, and other types of antibodies, for...

read more

Ronald Bowsher named alumnus of the year

Posted by on Jul 2, 2015 in News | 0 comments

B2S Labs Chief Scientific Officer Ronald Bowsher, Ph.D., was recently named the 2015 Alumnus of the Year by Beech Grove High School. He was honored in June, during the Beech Grove High School Alumni Association’s annual celebration dinner at Primo Banquet and Conference Center in Indianapolis, Indiana. Bowsher’s wife and three children are all alumni of Beech Grove High as well, and he went on to serve on the Beech Grove Schools Board of Education for about two decades. Professionally, Bowsher specializes in the development and...

read more

B2S Labs to attend AAPS conference

Posted by on Jun 5, 2015 in News | 0 comments

B2S Labs to attend AAPS conference

B2S Labs officials will be in California next week for the upcoming American Association of Pharmaceutical Scientists conference. Chief Scientific Officer Ronald Bowsher, Ph.D., and colleagues will attend on behalf of B2S Labs, the laboratory division of B2S Life Sciences. Bowsher is also president of B2S Consulting, the pharmaceutical consulting division of B2S Life Sciences, as well as a past president of AAPS. The 2015 AAPS National Biotechnology Conference is set for June 8 through June 10 in San Francisco. The association estimates that...

read more

Franklin College collaboration featured in IBJ

Posted by on May 19, 2015 in News | 0 comments

The partnership between B2S Labs® and Franklin College was recently featured in the magazine BioFutures. The magazine of the Indiana Health Industry Forum and Indiana Medical Device Manufacturers Council was published by the Indianapolis Business Journal (IBJ) as a special supplement. As part of the collaboration, B2S Labs® officers will lecture at Franklin College and the company will offer internships. B2S Labs® Chief Scientific Officer Ron Bowsher tells IBJ contributing editor Tom Harton that he hopes the partnership will open doors for...

read more

Franklin grants incentive for B2S Labs®

Posted by on May 5, 2015 in News | 0 comments

Franklin City Council members finalized a property tax abatement for B2S Labs® during their meeting Monday evening. The three-year incentive was approved in consideration of the new jobs that will be created as a result of B2S Labs® relocating to Franklin, Indiana. This type of abatement is possible under a state law aimed at vacant structures like the one into which B2S Labs® plans to invest about $1 million. The historic downtown building at 97 East Monroe Street has been vacant for a couple of years. Krista Linke, director of Franklin...

read more

B2S Labs® on the move

Posted by on Mar 2, 2015 in News | 0 comments

B2S Labs® is making headlines with a unique three-way partnership. The applied biotechnology firm that specializes in helping companies develop new biotherapeutic drugs is partnering with the city of Franklin to purchase a downtown building at 97 East Monroe Street — directly across from city hall. B2S Labs® plans to invest about $1 million worth of renovations in the vacant historic structure built in 1907, thereby expanding the city’s tax base and job offerings. The company aims to eventually hire up to 40 additional employees for...

read more
B2S Life Sciences